Anktiva
Payments companies reported to CMS as associated with Anktiva. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Anktiva, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Anktiva
These are the largest totals companies reported as associated with Anktiva. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Christopher Pieczonka | Syracuse, NY | Urology | $76,686.95 |
| Steven Finkelstein | New York, NY | Gastroenterology (Internal Medicine) | $18,375.55 |
| Gautam Jayram | Nashville, TN | Urology | $15,318.06 |
| Vahan Kassabian | Roswell, GA | Urology | $9,076.08 |
| Sam Chang | Nashville, TN | Urology | $8,034.49 |
| Lambros Stamatakis | Washington, DC | Urology | $5,464.62 |
| Edgardo Santos | Fort Lauderdale, FL | Hematology & Oncology | $5,000.00 |
| Michael Ahdoot | Los Angeles, CA | Urology | $4,837.40 |
| Suzanne Merrill | Lone Tree, CO | Urology | $4,322.81 |
| Timothy Henrich | Boston, MA | Internal Medicine | $4,125.00 |
Prescribed Anktiva?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.